All stories by Bs Reporter
Saffron surge to keep bulls on the front foot
Rediff.com17 May 2014It was a case of 'buy on hopes and sell on news' as the Indian market posted only modest gains despite a landslide victory to Narendra Modi-led Bharatiya Janata Party (BJP).
Wishlist for new PM: India Inc waits for reforms tsunami
Rediff.com17 May 2014Wishlist for new PM includes growth boosters, reining in inflation, faster project clearance and reversal of Land Acquisition Act
UPA gaffe: After raising fares, Railways puts it on hold
Rediff.com17 May 2014On a day the United Progressive Alliance government was voted out of power, it committed a gaffe by withdrawing a railway tariff hike within hours of announcing it.
'India Post can apply again for bank licence under new norms'
Rediff.com15 May 2014India Post had applied for a bank licence under RBI guidelines issued on February 22, 2013.
Sun Pharma moves SC against stay on Ranbaxy merger
Rediff.com15 May 2014Last month, the high court had ordered an interim status quo on the $4-billion deal, after a suit from some individual investors alleged insider trading in Ranbaxy's shares by Silverstreet Developers, Sun's wholly owned arm, before the deal was announced on April 6.
FM asks regulators to be alert, check market volatility
Rediff.com14 May 2014This was at a meeting of the Financial Stability and Development Council, chaired by him. Chidambaram, set to resign on Friday to make way for his successor, called upon the regulators and the ministry to be ready and take necessary action.
Exit polls' ripple effect: Rupee seen gaining as lotus blooms
Rediff.com13 May 2014The Street had factored in the NDA win, owing to which the appreciation in the rupee is expected to be limited
Now, NSEL brokers face police heat
Rediff.com8 May 2014Around 200 brokers are said to be involved in the scam; they have been summoned for questioning. Major brokerages questioned by the EoW so far include Anand Rathi, Motilal Oswal, India Infoline and Geojit Comtrade.
SC empowers CBI; jolt for Roy, BSES
Rediff.com7 May 2014CBI not to need prior approval to probe corrupt govt officials.
Rupee might weaken at start of the week
Rediff.com5 May 2014Government bonds yields are likely to trade in a range, owing to profit booking.
Reserve Bank appoints 3 new EDs
Rediff.com26 Apr 2014The central bank has nine executive directors, and one of them -- S Karuppasamy -- retired recently. R Gandhi, who was executive director, has now been promoted to the post of deputy governor.
MCX stake sale: Reliance Capital wants FMC to intervene
Rediff.com26 Apr 2014Largest bidder says FTIL not following correct process and MCX not extending cooperation; FTIL and MCX say cooperating fully
Walmart names China CEO Asia head
Rediff.com26 Apr 2014While the world's largest retail chain is calling it a promotion, experts said the group may be looking at a new growth strategy for Asia.
No undue benefit from KG gas, argues RIL
Rediff.com24 Apr 2014Reliance Industries on Wednesday assailed reports of the Comptroller and Auditor General and expert P Gopalakrishnan, which have alleged the company got undue benefits pertaining to Krishna-Godavari basin gas and its pricing.
China beats India by a huge margin
Rediff.com21 Apr 2014By 2013, the Chinese economy had become 2.7 times India's.
Tax authorities probing transactions between MCX-SX, FTIL
Rediff.com21 Apr 2014A special audit will look into any pricing anomalies in the transactions between the two, according to a source. FTIL had a contract for helping the exchange with its technology needs.
Infosys chief compliance officer quits
Rediff.com19 Apr 2014Company appoints Parvatheesam K as compliance officer.
Deals, Internet and sales staff can sway the consumer
Rediff.com17 Apr 2014Its studies have shown that the spending patterns of consumers -- particularly decision-makers -- can be influenced to a large degree with great deals, strong brand presence on the Internet, and productive person-to-person interactions.
Lodha buys 88 acres in Thane for Rs 1,154 crore
Rediff.com16 Apr 2014Consultants say at Rs 1,442 a sq ft, the developer has got a good bargain.
Sun Pharma makes open offer for Zenotech stake
Rediff.com13 Apr 2014Sun Pharma has evinced its interest in buying Hyderabad-based biotech company Zenotech Laboratories, through an open offer to buy 28.1 per cent worth Rs 18.41 crore ($3 million).